Gene · 2249
Papers3,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Large-Scale Analysis of X Inactivation Variations between Primed and Naïve Human Embryonic Stem Cells. | Cells | 2022 | 35681423 | PubTator, text mining | PubMed |
| Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases. | Oxid Med Cell Longev | 2022 | 35677107 | PubTator, text mining | PubMed |
| Microencapsulation-based cell therapies. | Cell Mol Life Sci | 2022 | 35674842 | PubTator, text mining | PubMed |
| Cell fate roadmap of human primed-to-naive transition reveals preimplantation cell lineage signatures. | Nat Commun | 2022 | 35672317 | PubTator, text mining | PubMed |
| Full-Length Transcriptional Analysis of the Same Soybean Genotype With Compatible and Incompatible Reactions to Heterodera glycines Reveals Nematode Infection Activating Plant Defense Response. | Front Plant Sci | 2022 | 35665156 | PubTator, text mining | PubMed |
Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice. | Stem Cell Res Ther | 2022 | 35659360 | PubTator, text mining | PubMed |
| Transcription factor networks in trophoblast development. | Cell Mol Life Sci | 2022 | 35657505 | PubTator, text mining | PubMed |
| Somatic non-cancerous overgrowth syndrome of obscure molecular etiology: what are the causes and options? | J Mol Med (Berl) | 2022 | 35657398 | PubTator, text mining | PubMed |
| Mouse Trophoblast Cells Can Provide IFN-Based Antiviral Protection to Embryonic Stem Cells via Paracrine Signaling. | J Immunol | 2022 | 35649628 | PubTator, text mining | PubMed |
| Cell-Based HIF1α Gene Therapy Reduces Myocardial Scar and Enhances Angiopoietic Proteome, Transcriptomic and miRNA Expression in Experimental Chronic Left Ventricular Dysfunction. | Front Bioeng Biotechnol | 2022 | 35646882 | PubTator, text mining | PubMed |
| Identification of a Cancer Stem Cells Signature of Head and Neck Squamous Cell Carcinoma. | Front Genet | 2022 | 35646104 | PubTator, text mining | PubMed |
| Mapping global trends in adipose-derived mesenchymal stem cell research: A bibliometric analysis using scopus database. | Ann Med Surg (Lond) | 2022 | 35638047 | PubTator, text mining | PubMed |
| Porcine Intestinal Organoids: Overview of the State of the Art. | Viruses | 2022 | 35632851 | PubTator, text mining | PubMed |
| TGFβ-Treated Placenta-Derived Mesenchymal Stem Cells Selectively Promote Anti-Adipogenesis in Thyroid-Associated Ophthalmopathy. | Int J Mol Sci | 2022 | 35628410 | PubTator, text mining | PubMed |
| Diagnostic Validation of a Comprehensive Targeted Panel for Broad Mutational and Biomarker Analysis in Solid Tumors. | Cancers (Basel) | 2022 | 35626061 | PubTator, text mining | PubMed |
| Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context. | Cancers (Basel) | 2022 | 35626056 | PubTator, text mining | PubMed |
| Structural characterization of fungus-specific histone deacetylase Hos3 provides insights into developing selective inhibitors with antifungal activity. | J Biol Chem | 2022 | 35623387 | PubTator, text mining | PubMed |
| Genomics and Immunomics in the Treatment of Urothelial Carcinoma. | Curr Oncol | 2022 | 35621673 | PubTator, text mining | PubMed |
Dextran sulfate prevents excess aggregation of human pluripotent stem cells in 3D culture by inhibiting ICAM1 expression coupled with down-regulating E-cadherin through activating the Wnt signaling pathway. | Stem Cell Res Ther | 2022 | 35619172 | PubTator, text mining | PubMed |
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. | BMC Cancer | 2022 | 35614407 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/papers?page=32